|
Company:
|
KAZIA THERAPEUTICS LTD (KZIA)
|
|
Form Type:
|
6-K
|
|
Filing Date:
|
6/23/2022
|
|
CIK:
|
0001075880
|
|
Address:
|
THREE INTERNATIONAL TOWERS LEVEL 24,
300 BARANGAROO AVENUE
|
|
City, State, Zip:
|
SYDNEY NSW, 2000
|
|
Telephone:
|
01161298780088
|
|
Fiscal Year:
|
06/30
|
|
|
|
|
|
Last Trade
|
Last Trade:
$1.28
|
Change:
0.02 (1.59%)
|
Trade Time:
Jun 07
|
Market Cap:
$17.76M
|
|
|
|
|
|
|
Description of Business
|
|
Kazia Therapeutics Limited ("Kazia"), a public company limited by shares, was
incorporated in March 1994 and registered in New South Wales, Australia. Kazia
is registered and operates under the Australian Corporations Act 2001.
Kazia has its registered office at Three International Towers, Level 24, 300
Barangaroo Avenue, Sydney, NSW 2000, Australia. Its telephone number and other
contact details are: Phone
+61-2-9472
4101; email info@kaziatherapeutics.com; and website,
www.kaziatherapeutics.com
(the information contained in the website does not form part of the Annual
Report). Our agent for service of process in the United States is Vcorp
Services, LLC, 25 Robert Pitt Drive, Suite 204, Monsey, New York 10952.
The Company's Ordinary Shares are listed on the Australian Securities Exchange
("ASX") under the symbol `KZA' and its ADSs, each representing ten Ordinary
Shares, trade on the NASDAQ Capital Market under the symbol `KZIA'.
|
|
|
|